LCN2 and breast carcinoma: Enhanced levels of lipocalin-2 (Lcn-2) were previously also associated with reduced disease-free survival in breast cancer patients [24], while inhibition of Lcn-2 significantly reduced mammary tumor progression and metastasis [25,26,27].